General Information of the Compound
| Compound ID |
CP0377155
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(2-hydroxy-3-(1-(5-methylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H26N4O3S
|
||||||||||||||||||
| Molecular Weight |
414.531
|
||||||||||||||||||
| Canonical SMILES |
Cc1csc2ncnc(N3CCC(CC3)NCC(O)COc3ccc(O)cc3)c12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H26N4O3S/c1-14-12-29-21-19(14)20(23-13-24-21)25-8-6-15(7-9-25)22-10-17(27)11-28-18-4-2-16(26)3-5-18/h2-5,12-13,15,17,22,26-27H,6-11H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
UUQDFZFJDFMLHW-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor